ProCE Banner Activity

Diapositivos: principais estudos de VIH que influenciam a minha prática após a semana IDWeek e VIH Glasgow 2022

Slideset Download
Conference Coverage

Reveja os resumos dos principais estudos de VIH dos membros do corpo docente especialistas do IDWeek e VIH Glasgow 2022, incluindo resultados de estudos de estratégias de prevenção, terapias de ação prolongada, terapias orais diárias, agentes de investigação e VIH e COVID-19.

Released: December 16, 2022

Share

Faculty

Karine Lacombe

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Karine Lacombe, MD, PhD: consultant/advisor/speaker: Gilead, Merck Sharp & Dohme, Viiv Healthcare.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GlaxoSmithKline, Merck Sharp & Dohme, ViiV.